Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Celadon Pharmaceuticals PLC (GB:CEL)
LSE:CEL
Celadon Pharmaceuticals PLC (CEL) Share Price & Analysis
6 Followers
CEL Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range55.00p - 155.00p
Previous Close59.5p
Volume42.74K
Average Volume (3M)50.55K
Market Cap
£39.40M
Enterprise Value34.45M
Total Cash (Recent Filing)$9.08M
Total Debt (Recent Filing)$4.59M
Price to Earnings (P/E)―
Beta-1.01
Next Earnings
Sep 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding65,982,712
10 Day Avg. Volume11,316
30 Day Avg. Volume50,547
Standard Deviation0.47
R-Squared0.02
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)18.54
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-8.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Celadon Pharmaceuticals PLC News
PremiumCompany Announcements
Celadon Pharmaceuticals Hits Harvest Milestone
PremiumCompany Announcements
Celadon Pharmaceuticals Expands Share Capital
PremiumCompany Announcements
Celadon Pharmaceuticals AGM Passes All Resolutions
PremiumCompany Announcements
Celadon Pharmaceuticals Expands Share CapitalPremiumCompany Announcements
Celadon Pharmaceuticals Announces AGM and Annual Report
PremiumCompany Announcements
Celadon Pharmaceuticals Expands to US Market
PremiumCompany Announcements
Celadon Pharmaceuticals Expands Share Capital
PremiumCompany Announcements
Celadon Pharmaceuticals Sees Strategic Progress Amid LossesOptions Prices
Currently, No data available
---
Ownership Overview
3.80%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
96.20% Public Companies and
Individual Investors
CEL FAQ
What was Celadon Pharmaceuticals PLC’s price range in the past 12 months?
Celadon Pharmaceuticals PLC lowest share price was 55.00p and its highest was 155.00p in the past 12 months.
What is Celadon Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Celadon Pharmaceuticals PLC’s upcoming earnings report date?
Celadon Pharmaceuticals PLC’s upcoming earnings report date is Sep 26, 2024 which is in 67 days.
How were Celadon Pharmaceuticals PLC’s earnings last quarter?
Celadon Pharmaceuticals PLC released its earnings results on May 14, 2024. The company reported -0.046p earnings per share for the quarter, missing the consensus estimate of N/A by -0.046p.
Is Celadon Pharmaceuticals PLC overvalued?
According to Wall Street analysts Celadon Pharmaceuticals PLC’s price is currently Overvalued.
Does Celadon Pharmaceuticals PLC pay dividends?
Celadon Pharmaceuticals PLC does not currently pay dividends.
What is Celadon Pharmaceuticals PLC’s EPS estimate?
Celadon Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celadon Pharmaceuticals PLC have?
Celadon Pharmaceuticals PLC has 66,220,810 shares outstanding.
What happened to Celadon Pharmaceuticals PLC’s price movement after its last earnings report?
Celadon Pharmaceuticals PLC reported an EPS of -0.046p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.439%.
Which hedge fund is a major shareholder of Celadon Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in GB:CEL
---
Celadon Pharmaceuticals PLC Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.98%
12-Months-Change
Fundamentals
Return on Equity
-131.82%
Trailing 12-Months
Asset Growth
-30.41%
Trailing 12-Months
Company Description
Celadon Pharmaceuticals PLC
Summerway Capital PLC operates as an investment holding company. It is focused on acquiring businesses that are either headquartered in the UK or that have substantial operations in the UK. The company is principally focused on opportunities in the wider household and consumer goods sector, including retail and consumer brands, particularly where there is an opportunity to introduce operational and performance improvements, including new technologies and associated operating and value leverage.
---
Technical Analysis
Best Analysts Covering CEL
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 10 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---